Compounds > sorafenib
Page last updated: 2024-09-05

sorafenib and 4-(4-(3-adamantan-1-ylureido)cyclohexyloxy)benzoic acid

sorafenib has been researched along with 4-(4-(3-adamantan-1-ylureido)cyclohexyloxy)benzoic acid in 1 studies

Compound Research Comparison

Studies
(sorafenib)		Trials
(sorafenib)		Recent Studies (post-2010)
(sorafenib)		Studies
(4-(4-(3-adamantan-1-ylureido)cyclohexyloxy)benzoic acid)		Trials
(4-(4-(3-adamantan-1-ylureido)cyclohexyloxy)benzoic acid)		Recent Studies (post-2010) (4-(4-(3-adamantan-1-ylureido)cyclohexyloxy)benzoic acid)
6,5207305,25123016

Protein Interaction Comparison

ProteinTaxonomysorafenib (IC50)4-(4-(3-adamantan-1-ylureido)cyclohexyloxy)benzoic acid (IC50)
Bifunctional epoxide hydrolase 2Homo sapiens (human)0.0014
Bifunctional epoxide hydrolase 2Mus musculus (house mouse)0.0049
Bifunctional epoxide hydrolase 2Rattus norvegicus (Norway rat)0.008
Epoxide hydrolase BMycobacterium tuberculosis CDC15513.4

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fu, SH; Hammock, BD; Hwang, SH; Morisseau, C; Nguyen, LV; Wecksler, AT; Zhang, G1

Other Studies

1 other study(ies) available for sorafenib and 4-(4-(3-adamantan-1-ylureido)cyclohexyloxy)benzoic acid

ArticleYear
Synthesis and biological evaluation of sorafenib- and regorafenib-like sEH inhibitors.
    Bioorganic & medicinal chemistry letters, 2013, Jul-01, Volume: 23, Issue:13

    Topics: Cell Proliferation; Dose-Response Relationship, Drug; Enzyme Inhibitors; Epoxide Hydrolases; Human Umbilical Vein Endothelial Cells; Humans; Molecular Structure; Niacinamide; Phenylurea Compounds; Pyridines; Solubility; Sorafenib; Structure-Activity Relationship

2013